Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced its financial results for the second quarter of fiscal year 2025.

In less than a month, Washington Square (and Holland) will have a new go-to spot for all things books and records.

HPE North America Channel Chief Jeremiah Jenson discusses his return to HPE after seven years at AWS, his top priorities and ...

If U.S. District Judge K. Michael Moore in Miami denies dismissal under Federal Rules of Civil Procedure 12(b)(6) or to ...

Venus Williams’ recent singles win at the D.C. Open showcased her longevity and brought attention to health coverage for ...

America has a real shot at ending its dangerous reliance on the People’s Republic of China (PRC) for rare earth ...

HBO launched HBO Family in 1996, an extension of the streamer with kid- and family-friendly content. With the termination of ...

Winners of the 2025 WealthManagement.com Industry Awards will be selected by an independent panel of industry judges and announced at the Wealthies Awards Ceremony, which will be held at the Cipriani ...

Q2 2025 Earnings Call Transcript July 24, 2025 TransUnion beats earnings expectations. Reported EPS is $1.08, expectations ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Insights into new beginnings, established practices, and the question of courage in the fashion industry. Trends and challenges ...